by GL Sciences
Inertsil ODS-4
The Most Deactivated Column Ever Made
GL Sciences’ newly-developed chemical bonding technology allows Inertsil ODS-4 to provide high efficiency and good peak shape where competitive columns fail. For example, in the examples at right, Inertsil ODS-4 is compared with competitive ODS phases for the analysis of basic and acidic compounds. Where other columns show poor peak shape, often with secondary interactions that result in prolonged retention, Inertsil ODS-4 delivers symmetric peaks with high efficiency.
Inertsil ODS-4 (and C8-4) is also available in 2 micron particle sizes for UHPLC.
| Vendor | GL Sciences | Max Pressure | 2900 |
| Brand | Inertsil ODS-4 | Surface Area | 450 |
| Modifification | Silica/C18 | Carbon Load, % | 11.0 |
| Mode | Reversed-Phase | Endcapped | Yes |
| Particle Size | Operating Temperature | 60 | |
| Length | pH stability from | 2.0 | |
| Internal Diameter | pH stability to | 7.5 | |
| Pore size | 100 |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| Chromenta | Chromenta KL C18 | Reversed-Phase | Silica/C18 | 4.6 mm | 300 mm | 5.0 μm | — | On request |
| Bonna-Agela Technologies | Durashell C18 (L) | Reversed-Phase | Silica/C18 | 4.6 mm | 100 mm | 3.0 μm | 150 Å | On request |
| WATERS | Spherisorb ODS1 | Reversed-Phase | Silica/C18 | 1.0 mm | 150 mm | 3.0 μm | 80 Å | On request |
| Greyhound | GenSphere ODS1 120 | Reversed-Phase | Silica/C18 | 7.0 mm | 250 mm | 5.0 μm | 120 Å | On request |
| Chromenta | Chromenta KAQ C18 | Reversed-Phase | Silica/C18 | 3.0 mm | 100 mm | 3.0 μm | 120 Å | On request |
| Vertical Chromatography | VertiSep AQS C18 | Reversed-Phase | Silica/C18 | 30.0 mm | 250 mm | 10.0 μm | 120 Å | On request |
| ES Industries | Chromegabond 120 BAS C18 | Reversed-Phase | Silica/C18 | 4.0 mm | 150 mm | 5.0 μm | 120 Å | On request |
| MACHEREY-NAGEL | NUCLEODUR C18 GRAVITY | Reversed-Phase | Silica/C18 | 3.0 mm | 50 mm | 1.8 μm | 110 Å | 439.00 |
No customer reviews yet. Be the first to share your experience!
Reach thousands of researchers worldwide. Fill in your details and our team will contact you shortly.
